Biopharmaceutical and clinical pharmacokinetic profile of bromazepam S. A. KaplanM. L. JackS. Cotler OriginalPaper 17 July 2015 Pages: 1 - 16
Contribution of the liver to overall elimination of propranolol Charles F. GeorgeMichael L'E OrmeColin T. Dollery OriginalPaper 17 July 2015 Pages: 17 - 27
Differential pulse polarographic assay procedure andin vitro biopharmaceutical properties of dipotassium clorazepate C. W. AbruzzoM. A. BrooksS. A. Kaplan OriginalPaper 17 July 2015 Pages: 29 - 41
Inappropriate use of the law of corresponding areas to calculate the time course of absorption for multicompartmental systems Renato L. GaleazziLeslie Z. Benet OriginalPaper 17 July 2015 Pages: 43 - 56
Ergot alkaloids: Hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine Fritz NimmerfallJoachim Rosenthaler OriginalPaper 17 July 2015 Pages: 57 - 66
Dose-effect curves and relative biophasic drug levels: Elucidation of these concepts and the illustration of their use for the determination of bioavailability, rate of absorption, and time course of pharmacological response William A. WeigandAshok K. Jhawar OriginalPaper 17 July 2015 Pages: 67 - 80